title: Rifampicin causes false-positive immunoassay results for urine opiates.
abstract: The treatment of tuberculosis usually includes the antibiotic rifampicin, especially in patients with concomitant human immunodeficiency virus infection. Some of these patients are in withdrawal therapy for drug abuse. When opiate screening is carried out in patients receiving rifampicin, false positive results are detected with the kinetic interaction of microparticles in solution method. We evaluated this interference in a Cobas-Integra analyzer and found a 12% cross-reactivity of rifampicin for antibiotic concentrations ranging from 0.19 to 6.08 mumol/l (156 to 5000 micrograms/l). This effect is not explained by the colour of the rifampicin solutions. Calculations assuming first order kinetics of elimination show that more than 18 hours after a single oral dose of 600 mg of rifampicin, a false positive result for opiates could be obtained. This indicates that the risk of a false positive result must always be considered when urine samples from these patients are analyzed.
authors.affiliation: Servicio de Bioquímica Clínica, Hospital Universitario de Getafe, Madrid, Spain. m.paula@recol-es
authors.forename: M
authors.initials: M
authors.lastname: de Paula
authors.forename: L C
authors.initials: LC
authors.lastname: Saiz
authors.forename: J
authors.initials: J
authors.lastname: González-Revaldería
authors.forename: T
authors.initials: T
authors.lastname: Pascual
authors.forename: C
authors.initials: C
authors.lastname: Alberola
authors.forename: E
authors.initials: E
authors.lastname: Miravalles
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000188:drug therapy / Q000652:urine; D000904:Antibiotics, Antitubercular / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000652:urine*; D005189:False Positive Reactions; D005260:Female; D006801:Humans; D007118:Immunoassay / Q000379:methods; D008297:Male; D008863:Microspheres; D009294:Narcotics / Q000652:urine*; D009293:Opioid-Related Disorders / Q000150:complications / Q000628:therapy / Q000652:urine; D012293:Rifampin / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000652:urine*; D014397:Tuberculosis, Pulmonary / Q000150:complications / Q000188:drug therapy / Q000652:urine
chemical_list: D000904:Antibiotics, Antitubercular; D009294:Narcotics; D012293:Rifampin